Beyond Restraint: The Clinical Utility of Enclosed Sleep Systems as Non-Restrictive Medical Devices for Injury Prevention and Sensory Regulation

A Clinical + Economic Case for Payer Coverage

Executive Summary

Each year, children with neurologic and neurodevelopmental conditions suffer preventable injuries and deaths during sleep. Falls during seizures, elopement from the home, and self-injurious behavior during unsupervised nighttime hours are documented, recurring safety hazards for children with autism spectrum disorder, epilepsy, cerebral palsy, traumatic brain injury, and other conditions that require a physically safe sleep environment.

Enclosed bed systems are medical safety devices designed to prevent these outcomes. A peer-reviewed study found caregiver-reported reductions in injuries and up to 50% fewer elopement incidents, and sleep duration increases from 4-6 hours to 8-10 hours per night.¹ Federal law explicitly distinguishes protective devices from restraints.^2,3 The National Coalition for Assistive and Rehab Technology (NCART) has formally affirmed that enclosed beds are medically necessary devices, not restraints.⁴ At least sixteen state Medicaid programs and eleven commercial payers have established coverage policies (see Appendix A).

An enclosed bed is typically medically appropriate when three criteria are met:

• A documented neurological condition produces safety-relevant functional impairment;
• Objective evidence of safety risk, including likelihood of injury and/or history, elopement events, or ED visits; and
• Less restrictive alternatives have been tried or considered and found insufficient.

This is the same prescribing framework used for wheelchairs, hospital beds, and adaptive seating.

The one-time cost of the device is a fraction of what payers spend annually on the emergency visits, hospitalizations, and residential placements it prevents. Denials based on a blanket “restraint” characterization misapply the regulatory standard, increase system costs, and leave children exposed to preventable harm.

The Clinical Need

The children who require enclosed bed systems share a common clinical profile: brain-based medical conditions that produce objective, measurable safety impairments during sleep. These are neurological conditions with well-characterized pathophysiology. They are not behavioral diagnoses, and they are not parenting challenges.

Autism spectrum disorder affects 1 in 36 U.S. children.⁵ Up to eighty percent experience chronic sleep disturbances.⁶ Forty-nine percent attempt to elope from safe environments,⁷ and 42% engage in self-injurious behavior.⁸ Children with ASD face a drowning risk approximately 40 times higher than neurotypical peers, making nighttime elopement a potentially fatal event.⁹ These behaviors are driven by neurological differences in executive function, sensory processing, and threat perception, not by willful disobedience or caregiver failure.

Epilepsy affects approximately 470,000 U.S. children.¹⁰ Nocturnal seizures cause falls, aspiration, and contribute to Sudden Unexpected Death in Epilepsy (SUDEP), which claims approximately 1 in 1,000 epilepsy patients per year.¹¹ An enclosed safety bed does not prevent seizures — but it prevents the secondary injuries that seizures in a standard bed can cause.

Children with cerebral palsy, traumatic brain injury, and genetic conditions such as Angelman syndrome and Rett syndrome present similar safety profiles: impaired safety awareness, involuntary movement, disrupted sleep architecture, and inability to self-rescue after injury. Indiana Medicaid’s coverage criteria reflect this broad clinical scope, listing qualifying diagnoses including severe intellectual disabilities, leukodystrophy, hydrocephalus, infantile cerebral palsy, generalized epilepsy, anoxic brain damage, and intracranial injury.¹²

Nighttime is inherently unsupervised. Caregivers must sleep. But for many of these children, nighttime is not eight hours of sleep — it is one to two hours of fragmented sleep interspersed with hours of active wakefulness spent stimming, attempting to elope, or engaging in self-injurious behavior. The level of supervision required is equivalent to daytime one-on-one care, sustained across every night indefinitely — a demand no family can maintain without intervention. Standard home modifications are routinely insufficient. In a New York State external appeal, a family documented failed attempts with toddler beds, bed rails, audio/visual monitoring, child-proofing, white noise machines, door alarms, and doorway gates before the enclosed bed was found medically necessary.¹³

When nighttime safety events go unaddressed, they cascade: emergency department visits, hospitalizations, child protective services involvement, and out-of-home placement. Each costs the healthcare system far more than the device that would have prevented it.

Safety Device, Not Restraint: The Regulatory Framework

The characterization of enclosed beds as “restraints” arises from an overly broad reading of restraint definitions never intended to apply to home-use medical safety devices prescribed for injury prevention. Federal law, industry standards, and clinical practice all draw a clear line between protective devices and restraints.²

Federal Law

Two federal statutes explicitly carve out protective safety devices from restraint definitions:

The CMS conditions of participation for hospitals state that a restraint does not include devices used “to protect the patient from falling out of bed, or to permit the patient to participate in activities without the risk of physical harm,” provided they do not immobilize or reduce the ability to move beyond what is clinically necessary.²

The Protection and Advocacy for Individuals with Mental Illness Act contains parallel language excluding protective devices from the restraint definition.³

These statutes establish a principle that should carry through to coverage decisions: when a device’s purpose is injury prevention for a person who cannot protect themselves, and it is prescribed as part of a documented care plan, it is a protective device, not a restraint. The distinction turns on purpose and function, not on the physical characteristics of the device.

Industry Consensus

NCART’s formal position statement defines an adaptive/protective bed as “a medical device, registered with the FDA, prescribed specifically for an individual of any age with a medically established diagnosis, disability, or complex medical condition.” The statement affirms: “Devices to protect the beneficiary from falling out of bed or to permit participation in activities without risk of physical harm are NOT restraints.” Clinical studies support this position. A clinical review of 208 pediatric enclosure bed encounters concluded that enclosed beds are a reasonable intervention to ensure safety in children with cognitive impairments.¹⁴

Protective Devices in Context

Enclosed beds are not the first protective device to face this objection. Car seats physically prevent a child from moving freely, yet no one calls them restraints because their purpose is injury prevention. The National Transportation Safety Board has documented that child restraint systems reduce fatal injury risk by 71% for infants and 54% for toddlers.¹⁵ That evidence transformed car seats from optional accessories into legally mandated safety devices. Enclosed beds warrant the same recognition: a protective device, prescribed for a vulnerable population, with documented reductions in harm. Cribs are enclosed sleeping environments designed to contain infants and toddlers during sleep. Wheelchair harnesses prevent falls for patients with impaired trunk control. An enclosed bed is the developmentally appropriate equivalent of a crib for an older child whose neurological condition creates the same safety risks that a crib addresses for an infant but with enhanced features to accommodate for medical conditions that prevent use of a commercial crib.

It is worth noting that some alternative solutions payers have suggested, such as bedroom door locks or window bars, create their own safety hazards (fire code violations, entrapment risk) while offering less protection than a purpose-built medical device with padded surfaces and proper ventilation.

Clinical Evidence

The evidence base for enclosed bed systems includes peer-reviewed research, health economics analysis, and documented real-world outcomes across multiple states.

A 2025 peer-reviewed study of caregiver-reported outcomes for children using sensory safety beds found that while melatonin offered limited relief — sleep latency of 20–40 minutes¹⁶ — the Cubby Bed resulted in a median increase in sleep duration from 4–6 hours to 8–10 hours per night and a reduction in injuries.¹ Given that up to 80% of children with ASD experience chronic sleep disturbances ⁶ and that sleep deprivation compounds cognitive, behavioral, and medical challenges,¹⁷ this improvement in sleep alone represents a clinically significant outcome.

A randomized clinical trial comparing safe enclosure systems to standard restraints in a hospital setting documented zero injuries in the enclosure group versus injuries in the standard restraint group during the study period. These findings suggest that, in a hospital setting, enclosure-based approaches may be comparable or safer than traditional restraints.¹⁸

These findings converge across different methodologies and settings: when used for the right patients, enclosed beds are designed to reduce injuries, reduce elopement, and substantially improve the child’s sleep duration. For children with neurological conditions, this additional sleep is not merely restorative — it directly affects seizure threshold, behavioral regulation, cognitive function, and the capacity to benefit from daytime therapies.^19,20

The Economic Case

The economic logic for enclosed bed coverage is straightforward: a one-time DME purchase versus the recurring annual costs of the events it prevents.

A single pediatric emergency department visit averages $440.²¹ A non-birth pediatric inpatient admission averages $13,400.²² When nighttime safety failures lead to caregiver breakdown and out-of-home residential placement, Medicaid costs escalate to approximately $129,000 per child per year.²³ These are not hypothetical scenarios — they are the documented outcomes for children whose nighttime safety needs go unaddressed.

An enclosed bed system costs approximately $11,000 to $15,000 with a useful life of five years. A device that prevents even one inpatient admission per year recovers its cost. A device that prevents a single residential placement pays for itself many times over. For payers evaluating budget impact, detailed population-specific analyses are available upon request.

Appropriate Use and Safeguards

Any medical device can be misused. The relevant question is not whether misuse is theoretically possible, but whether appropriate safeguards exist and whether the benefits of proper use outweigh the risks.

The cases of misuse that have drawn public scrutiny involved makeshift enclosures or homemade structures, not FDA-registered devices prescribed through clinical channels. Denying coverage does not prevent misuse. It prevents appropriate use. Families whose children face genuine safety risks do not stop looking for solutions when insurance denies an enclosed bed. They turn to makeshift alternatives that lack the safety engineering, padding, ventilation, and clinical oversight of a prescribed medical device.

An enclosed bed is typically medically appropriate when three criteria are met:

• A documented neurological condition produces safety-relevant functional impairment;
• Objective evidence of safety risk, including likelihood of injury and/or history, elopement events, or ED visits; and
• Less restrictive alternatives have been tried or considered and found insufficient.

This is the same prescribing framework used for wheelchairs, hospital beds, and adaptive seating.

Multiple safeguards are built into the prescribing process: physician prescription based on documented necessity, manufacturer instructions specifying use during sleeping and resting periods, periodic reassessment, and caregiver training. Several states add further requirements, including Minnesota’s requirement for an occupational or behavioral therapist evaluation and documentation that less costly alternatives have been attempted and failed.²⁴

EPSDT: A Legal Obligation, Not a Coverage Option

For Medicaid-enrolled children under 21, enclosed bed coverage is not discretionary. The EPSDT provision requires states to cover any medically necessary service that will “correct or ameliorate” a child’s condition — “whether or not such services are covered under the State plan."²⁵ When a physician prescribes an enclosed bed for a child with a documented neurological condition, and the device prevents injury, enables sleep, and reduces elopement, the EPSDT standard is met.

Courts have enforced this obligation. In Rosie D. v. Romney, a federal court held that “if a licensed clinician finds a particular service to be medically necessary to help a child improve his or her functional level, this service must be paid for."²⁶In S.D. v. Hood, the Fifth Circuit ruled that states have “an obligatory, not discretionary, duty” to provide EPSDT services, even for items not in the state plan.²⁷ CMS guidance reinforces that EPSDT requires a “higher standard of coverage for eligible children than for adults."²⁸

“Not in our state plan” is not a defense to an EPSDT claim — it is the exact scenario the statute was written to address. A Wisconsin administrative law judge has already overturned an enclosed bed denial on these grounds.²⁹ States that categorically exclude enclosed beds are not reducing liability — they are accumulating it.

When Coverage Is Denied

When a child’s nighttime safety needs go unmet, the burden falls entirely on caregivers. Parents of children with ASD experience objectively measured sleep loss, with the majority meeting clinical criteria for poor sleep quality.³⁰ Caregiver stress is among the strongest predictors of out-of-home placement for children with developmental disabilities.³¹ When caregivers can no longer sustain nighttime vigilance, the result is residential placement at approximately $129,000 per child per year.²³ A single prevented placement pays for roughly ten enclosed beds. The device that costs $11,000 is not the expensive option — the placement that follows its denial is.

Families and clinicians also turn to sedating medications when no physical safety solution is available. Risperidone, clonidine, trazodone, and benzodiazepines are prescribed off-label to manage nighttime agitation, elopement, and self-injury. A federal review found that 92% of second-generation antipsychotics prescribed to children on Medicaid were for indications without FDA approval.³² CMS has required all states to implement monitoring of pediatric antipsychotic prescribing as a quality concern.³³ An enclosed bed addresses the environmental hazard directly. Chemical sedation suppresses the child without addressing it.

Coverage Landscape and Recommendations

Multiple state Medicaid programs and major commercial payers have established coverage policies for enclosed bed systems. We have identified formal coverage criteria or medical policies addressing enclosed beds in at least sixteen states and from at least eleven commercial insurers (see Appendix A).

Appeal decisions have supported coverage when clinical documentation is thorough. In New York, a state external appeal overturned a denial after the family documented the medical safety purpose and failure of less restrictive alternatives.¹³ In Wisconsin, an administrative law judge reached a similar conclusion for a child with a genetic disorder, finding the enclosed bed medically necessary under EPSDT.²⁹

The EPSDT mandate, detailed in the preceding section, establishes a federal legal obligation: for children under 21, Medicaid must cover any medically necessary service or device to “correct or ameliorate” a condition, even if not explicitly listed in the state plan.²⁵ Multiple appeal decisions and enforcement actions have already established precedent for enclosed bed coverage under this standard.

We recommend that payers:

• Recognize that enclosed bed systems are durable medical equipment.
• Establish coverage criteria based on documented neurological diagnosis, objective safety risk, and trial of less restrictive alternatives, using existing Medicaid and commercial payer coverage criteria as templates.
• Recognize that non-coverage and denials shift costs, not reduce them — to emergency departments, inpatient units, and institutional placements that far exceed the one-time cost of the device.

The clinical evidence, regulatory precedent, and economic data support the same conclusion. Enclosed bed systems are medically necessary safety devices. Multiple states and payers have already reached this determination. The remaining question is whether additional payers will act on the evidence to protect these children.

Appendix A: State Medicaid and Commercial Payer Coverage Policies

The following state Medicaid programs and commercial payers have established formal coverage criteria or medical policies addressing enclosed bed systems. URLs were verified as of February 2026.

Frequently Asked Questions